GENE ONLINE|News &
Opinion
Blog

Clinical Trial
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
FDA Lifts Hold on LogicBio’s Gene Editing Program
2022-05-10
REVEAL GENOMICS and Dana-Farber Cancer Institute Team Up to Research Breast Cancer
2022-04-29
These Two Companies are Helping Push Denmark to the Forefront of Biotech
2022-04-21
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
2022-03-30
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
FDA Announces Draft Guidances on Genome Editing and CAR T Cell Therapy
2022-03-25
No Real-Life Placebo Required – Deriving Virtual Control Group Data by Machine Learning
2022-03-16
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Are Decentralized Clinical Trials Taking Root in Japan?
2021-10-29
1 2 3 4 14
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top